# PCD New Gene Discovery

> **NCT03801395** · — · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Primary Ciliary Dyskinesia

## Interventions

- **OTHER:** There is no intervention

## Key facts

- **NCT ID:** NCT03801395
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-07
- **Primary completion:** 2020-07-01
- **Final completion:** 2024-11-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801395, "PCD New Gene Discovery". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03801395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*